Meanwhile, Chinese companies are rapidly advancing through fast following, innovation and licensing, with key developments including Innovents mazdutide, Innogens supaglutide, Hengruis oral candidate HRS-7535, United Laboratories licensing of its first-in-class triple-G (GLP-1, gastric inhibitory polypeptide (GIP) and glucagon) a gonist to Novo Nordisk and Ascletis positive Phase 1 results for its oral + injection candidate, ASC30
While semaglutide is generally tolerated pretty well, it could come with several side effects
How the Compounding Market Got So Large Compounded GLP-1s existed for one specific legal reason: FDA-declared drug shortages
Cryptocurrency2 months ago Most Crypto Hacks Dont Start With Stolen WalletsThey Start in the Code Five of the top ten crypto hacking methods exploit code vulnerabilities
One of those researchers is Georgia State University Professor of Neuroscience and Georgia Research Alliance Distinguished Investigator Eric Krause
For employers, this is important because pharmacy benefits are often the part of the plan employees use most often